SEC Form 4 · accession 0001127602-18-009309

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Corporate Executive VP & CFO

Period of report

Feb 27, 2018

Accepted (ET)

Mar 1, 2018 · 12:50 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2018	M	2,158	$76.67	A	16,236	D
Common Stock	Feb 27, 2018	S	100	$107.45	D	16,136	D
Common Stock	Feb 27, 2018	S	100	$107.67	D	16,036	D
Common Stock	Feb 27, 2018	S	100	$107.80	D	15,936	D
Common Stock	Feb 27, 2018	S	100	$107.81	D	15,836	D
Common Stock	Feb 27, 2018	S	200	$107.88	D	15,636	D
Common Stock	Feb 27, 2018	S	100	$107.90	D	15,536	D
Common Stock	Feb 27, 2018	S	100	$107.96	D	15,436	D
Common Stock	Feb 27, 2018	S	100	$108.04	D	15,336	D
Common Stock	Feb 27, 2018	S	258	$108.13	D	15,078	D
Common Stock	Feb 27, 2018	S	100	$108.17	D	14,978	D
Common Stock	Feb 27, 2018	S	100	$108.22	D	14,878	D
Common Stock	Feb 27, 2018	S	100	$108.23	D	14,778	D
Common Stock	Feb 27, 2018	S	100	$108.24	D	14,678	D
Common Stock	Feb 27, 2018	S	100	$108.32	D	14,578	D
Common Stock	Feb 27, 2018	S	100	$108.35	D	14,478	D
Common Stock	Feb 27, 2018	S	100	$108.41	D	14,378	D
Common Stock	Feb 27, 2018	S	100	$108.45	D	14,278	D
Common Stock	Feb 27, 2018	S	100	$108.49	D	14,178	D
Common Stock	Feb 27, 2018	S	100	$108.58	D	14,078	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)	$76.67	Feb 27, 2018	M	2,158	D	Feb 27, 2016	Feb 27, 2020	Common Stock	2,158	2,158	D